Lina_S

About Lina Silva Salinas

This author has not yet filled in any details.
So far Lina Silva Salinas has created 417 blog entries.

Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial

2021-07-29T22:38:06+02:00

Perrone F, Nuzzo F, Di Rella F, Gravina A, Iodice G, Labonia V, Landi G, Pacilio C, Rossi E, De Laurentiis M, D'Aiuto M, Botti G, Forestieri V, Lauria R, De Placido S, Tinessa V, Daniele B, Gori S, Colantuoni G, Barni S, Riccardi F, De Maio E, Montanino A, Morabito A, Daniele G, Di Maio M, Piccirillo MC, Signoriello S, Gallo C, de Matteis A. Ann Oncol. 2015 Apr;26(4):675-82. doi: 10.1093/annonc/mdu564. Epub 2014 Dec 8. (Pubmed)

Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial2021-07-29T22:38:06+02:00

A Belgian survey on geriatric assessment in oncology focusing on large-scale implementation and related barriers and facilitators

2021-07-29T22:38:06+02:00

C. Kenis, P. Heeren, L. Decoster, K. Van Puyvelde, G. Conings, F. Cornelis, P. Cornette, R. Moor, S. Luce, Y. Libert, R. Van Rijswijk, G. Jerusalem, M. Rasschaert, C. Langenaeken, A. Baitar, P. Specenier, K. Geboers, K. Vandenborre, P. R. Debruyne, K. Vanoverbeke, H. Van Den Bulck, J.-P. Praet, C. Focan, V. Verschaeve, N. Nols, J.-C. Goeminne, B. Petit, J.-P. Lobelle, J. Flamaing, K. Milisen, Hans Wildiers. The journal of nutrition, health & aging May 2015 (Journal of nutrition, health & aging)

A Belgian survey on geriatric assessment in oncology focusing on large-scale implementation and related barriers and facilitators2021-07-29T22:38:06+02:00

Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis

2021-07-29T22:38:07+02:00

van Ravesteyn NT, Stout NK, Schechter CB, Heijnsdijk EA, Alagoz O, Trentham-Dietz A, Mandelblatt JS, de Koning HJ.  J Natl Cancer Inst. 2015 May 6;107(7). pii: djv103. doi: 10.1093/jnci/djv103. Print 2015 Jul. (Pubmed)

Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis2021-07-29T22:38:07+02:00
Go to Top